T6	Subject 0 34	A patient with Parkinson's disease
T7	Treatment 36 106	initially treated with bromocriptine and subsequently with cabergoline
T5	Effect 118 185	progressive pleuropulmonary abnormalities during the latter therapy
T8	Sub-Disorder 15 34	Parkinson's disease
T9	Drug 59 72	bromocriptine
T10	Drug 95 106	cabergoline
